171 related articles for article (PubMed ID: 29567579)
1. Palliative shunt surgery for patients with leptomeningeal metastasis.
Murakami Y; Ichikawa M; Bakhit M; Jinguji S; Sato T; Fujii M; Sakuma J; Saito K
Clin Neurol Neurosurg; 2018 May; 168():175-178. PubMed ID: 29567579
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.
Kim HS; Park JB; Gwak HS; Kwon JW; Shin SH; Yoo H
World J Surg Oncol; 2019 Mar; 17(1):59. PubMed ID: 30917830
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosis.
Su YH; Chiang CL; Yang HC; Hu YS; Chen YW; Luo YH; Chen CJ; Wu HM; Lin CJ; Lee CC
Acta Neurochir (Wien); 2022 Feb; 164(2):459-467. PubMed ID: 33646444
[TBL] [Abstract][Full Text] [Related]
4. Palliative lumboperitoneal shunt for leptomeningeal metastasis-related hydrocephalus: A case series.
Yamashiro S; Hitoshi Y; Tajiri S; Uchikawa H; Ito K; Yoshida A; Kuratsu JI
Palliat Med; 2017 Jan; 31(1):93-96. PubMed ID: 27188875
[TBL] [Abstract][Full Text] [Related]
5. Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
Mitsuya K; Nakasu Y; Hayashi N; Deguchi S; Takahashi T; Murakami H; Naito T; Kenmotsu H; Ono A; Wakuda K; Harada H
PLoS One; 2019; 14(1):e0210074. PubMed ID: 30629621
[TBL] [Abstract][Full Text] [Related]
6. Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis.
Lee SH; Kong DS; Seol HJ; Nam DH; Lee JI
J Neurooncol; 2011 Sep; 104(2):545-51. PubMed ID: 21274592
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
8. Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case.
Lu VM; Abou-Al-Shaar H; Bin-Alamer O; Luther EM; Benjamin CG
J Neurooncol; 2023 May; 163(1):29-37. PubMed ID: 37191912
[TBL] [Abstract][Full Text] [Related]
9. Ventriculoperitoneal shunt in patients with leptomeningeal metastasis.
Omuro AM; Lallana EC; Bilsky MH; DeAngelis LM
Neurology; 2005 May; 64(9):1625-7. PubMed ID: 15883329
[TBL] [Abstract][Full Text] [Related]
10. One-year outcome in patients with idiopathic normal-pressure hydrocephalus: comparison of lumboperitoneal shunt to ventriculoperitoneal shunt.
Miyajima M; Kazui H; Mori E; Ishikawa M;
J Neurosurg; 2016 Dec; 125(6):1483-1492. PubMed ID: 26871203
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Palliative Cerebrospinal Fluid Shunting for Patients With Leptomeningeal Carcinomatosis-related Hydrocephalus.
Yoshioka H; Okuda T; Nakao T; Fujita M; Takahashi JC
Anticancer Res; 2021 Aug; 41(8):4169-4172. PubMed ID: 34281889
[TBL] [Abstract][Full Text] [Related]
12. Lumboperitoneal shunt for the treatment of leptomeningeal metastasis.
Zhang XH; Wang XG; Piao YZ; Wang P; Li P; Li WL
Med Hypotheses; 2015 May; 84(5):506-8. PubMed ID: 25754849
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes.
Bander ED; Yuan M; Reiner AS; Garton ALA; Panageas KS; Brennan CW; Tabar V; Moss NS
J Neurooncol; 2021 Sep; 154(3):301-313. PubMed ID: 34406564
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Preoperative Radiological Risk Features in Patients with Leptomeningeal Carcinomatosis Undergoing Cerebrospinal Fluid Drainage.
Hou Q; Mo Y; Guo J; Deng T; Mo L; Wei C
World Neurosurg; 2024 Jun; 186():e614-e621. PubMed ID: 38593911
[TBL] [Abstract][Full Text] [Related]
15. Challenges in cerebrospinal fluid shunting in patients with glioblastoma.
Hong B; Polemikos M; Heissler HE; Hartmann C; Nakamura M; Krauss JK
Fluids Barriers CNS; 2018 Jun; 15(1):16. PubMed ID: 29860942
[TBL] [Abstract][Full Text] [Related]
16. What is the risk of a shunt malfunction after elective intradural surgery?
Venable GT; Green CS; Smalley ZS; Bedford EC; Modica JS; Klimo P
J Neurosurg Pediatr; 2015 Dec; 16(6):642-7. PubMed ID: 26359674
[TBL] [Abstract][Full Text] [Related]
17. [A case of lumboperitoneal shunt as an effective palliative tool in a patient with leptomeningeal metastasis].
Yamashiro S; Yoshida AO; Tajiri S; Anal S; Ito K; Kuratsu J
No Shinkei Geka; 2009 Oct; 37(10):1007-11. PubMed ID: 19882962
[TBL] [Abstract][Full Text] [Related]
18. Obstructive hydrocephalus in adult patients: the Louisiana State University Health Sciences Center-Shreveport experience with ventriculoperitoneal shunts.
Reddy GK; Shi R; Nanda A; Guthikonda B
World Neurosurg; 2011; 76(1-2):176-82. PubMed ID: 21839971
[TBL] [Abstract][Full Text] [Related]
19. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study.
Lin N; Dunn IF; Glantz M; Allison DL; Jensen R; Johnson MD; Friedlander RM; Kesari S
J Neurosurg; 2011 Oct; 115(4):730-6. PubMed ID: 21721878
[TBL] [Abstract][Full Text] [Related]
20. [Multidisciplinary treatment of leptomeningeal metastasis in patients with lung adenocarcinoma: the triple modality combination of EGFR-TKI, VP shunt and irradiation].
Mitsuya K; Nakasu Y; Mizokami Y; Takahashi T; Nakamura Y; Ono A; Toda Y; Yamamoto N; Harada H; Nishimura T
No Shinkei Geka; 2012 Jun; 40(6):503-9. PubMed ID: 22647509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
